Robert Epstein

Summary

Affiliation: Medco Health Solutions
Country: USA

Publications

  1. ncbi What's needed for personalized therapy in smoking cessation
    R S Epstein
    Medco Health Solutions, Franklin Lakes, New Jersey, USA
    Clin Pharmacol Ther 84:309-10. 2008
  2. ncbi Payer perspectives on pharmacogenomics testing and drug development
    Robert S Epstein
    Medco Health Solutions, Inc, 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA
    Pharmacogenomics 10:149-51. 2009
  3. ncbi Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)
    Robert S Epstein
    Department of Medical and Analytical Affairs, Medco Health Solutions, Inc, Franklin Lakes, New Jersey 07417, USA
    J Am Coll Cardiol 55:2804-12. 2010
  4. ncbi Comparative effectiveness and personalized medicine: evolving together or apart?
    Robert Epstein
    Medco ResearchInstitute, Medco Health Solutions, Franklin Lakes, New Jersey, USA
    Health Aff (Millwood) 29:1783-7. 2010
  5. ncbi Pharmacy benefit managers: evaluating clinical utility in the real world
    R S Epstein
    Medco Health Solutions, Inc, Franklin Lakes, New Jersey, USA
    Clin Pharmacol Ther 88:880-2. 2010

Detail Information

Publications5

  1. ncbi What's needed for personalized therapy in smoking cessation
    R S Epstein
    Medco Health Solutions, Franklin Lakes, New Jersey, USA
    Clin Pharmacol Ther 84:309-10. 2008
    ..This approach could greatly improve the overall effectiveness of smoking-cessation agents and generate cost savings that might in turn have the effect of influencing more payers to cover these agents...
  2. ncbi Payer perspectives on pharmacogenomics testing and drug development
    Robert S Epstein
    Medco Health Solutions, Inc, 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA
    Pharmacogenomics 10:149-51. 2009
    ..The panel was generally enthusiastic about the promise of the field to improve drug selection or dosing...
  3. ncbi Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)
    Robert S Epstein
    Department of Medical and Analytical Affairs, Medco Health Solutions, Inc, Franklin Lakes, New Jersey 07417, USA
    J Am Coll Cardiol 55:2804-12. 2010
    ..This study was designed to determine whether genotype testing for patients initiating warfarin treatment will reduce the incidence of hospitalizations, including those due to bleeding or thromboembolism...
  4. ncbi Comparative effectiveness and personalized medicine: evolving together or apart?
    Robert Epstein
    Medco ResearchInstitute, Medco Health Solutions, Franklin Lakes, New Jersey, USA
    Health Aff (Millwood) 29:1783-7. 2010
    ..Thus, comparative effectiveness research can help discern the appropriate role of personalized medicine in improving health care outcomes and rationalizing costs...
  5. ncbi Pharmacy benefit managers: evaluating clinical utility in the real world
    R S Epstein
    Medco Health Solutions, Inc, Franklin Lakes, New Jersey, USA
    Clin Pharmacol Ther 88:880-2. 2010
    ..It is the unique “wired” interactive role in the health-care system that enables PBMs to play an emerging role in evaluating the clinical utility of biomarkers...